Syntara Limited (SNT) Earnings Call Transcript & Summary

January 30, 2024

Australian Securities Exchange AU Health Care Pharmaceuticals shareholder_meeting 6 min

Earnings Call Speaker Segments

David McGarvey

executive
#1

Good morning. Welcome to our General Meeting of Syntara Limited, which has been called by Notice of Meeting dated 29 December 2023. We have a quorum, and I now declare the meeting open. My name is David McGarvey, the company Secretary and Chief Financial Officer of Syntara. Today's meeting is being held as a virtual meeting via live webcast with the use of the Zoom platform and also the Computershare meeting platform for voting. Shareholders and proxies have the ability to ask questions via Zoom and submit votes via the Computershare meeting platform. You need to be logged on to both platforms if you wish to participate and vote. Firstly, let me briefly introduce our Board. Dr. Kathleen Metters, Non-Executive Chair.

Kathleen M. Metters

executive
#2

Good morning.

David McGarvey

executive
#3

Mr. Gary Phillips, our CEO.

Gary Phillips

executive
#4

Good morning.

David McGarvey

executive
#5

Dr. Simon Green, Non-Executive Director.

Simon Green

executive
#6

Good morning, all.

David McGarvey

executive
#7

Mr. Hashan De Silva, Non-Executive Director.

Hashan De Silva

executive
#8

Good morning.

David McGarvey

executive
#9

We will take the Notice of Meeting and the Proposed Resolutions as read, but we will also display them as the meeting progresses. Questions can be submitted online at any time. For shareholders and proxies wishing to submit a written question, select the Q&A button in the center of the bottom toolbar, then type out your question in the text box provided and submit. Please note that while you can submit questions from now on, we will address them at the relevant times in the meeting, which will be after proposing each item of business. If shareholders and proxies would like to submit your question verbally, click the raise hand button in the center of the bottom toolbar at the appropriate time when we ask questions. When the presenter then prompts you to ask your question, you will be provided with microphone access and the system will ask you to confirm your microphone settings. And once confirmed, you'll be able to speak. Please introduce yourself and advise whether you're a shareholder or a proxy holder. Voting today will be conducted by way of a poll on all items of business using the Computershare meeting platform. In order to provide you with enough time to vote, voting is now open for all resolutions. If you are eligible to vote at this meeting, a new polling icon has or will shortly appear on the Computershare meeting platform. Selecting this icon will bring up a list of resolutions and present you with voting options. To cast your vote, simply select one of the options. There is no need to hit a submit or an end button as the vote is automatically recorded. You have the ability to change your vote up until the time we declare voting closed, which will be towards the end of the meeting. I would now like to hand over to the Chair of the company and of this meeting, Dr. Kathleen Metters.

Kathleen M. Metters

executive
#10

Thank you, David, and good morning. The purpose of today's meeting is to ratify and approve the issuance of shares as part of our recently announced 2-tranche placement. The company is also seeking approval for an associate of one of our directors, Dr. Simon Green to acquire shares in Tranche 2 of the placement. At the outset, I would like to thank all our existing and substantial shareholders for their strong support and to welcome new investors to our register. We will proceed with the formal items of business. So Resolution 1. Resolution 1 is an ordinary resolution that relates to the ratification of the issue of shares under the first tranche of placement that we announced in December 2023 in order to refresh the company's 15% capacity. Voting exclusions apply in respect to Resolution 1. The proxy votes received prior to the meeting are set out online. Are there any questions?

David McGarvey

executive
#11

There are no questions.

Kathleen M. Metters

executive
#12

Resolution 2. Resolution 2 is an ordinary resolution that relates to the approval of the proposed issue of shares under the second tranche of the placement, again that we announced in December 2023. Voting exclusions apply with respect to Resolution 2. And does anyone have any questions in relation to Resolution 2?

David McGarvey

executive
#13

No questions.

Kathleen M. Metters

executive
#14

Resolution 3. Resolution 3 is an ordinary resolution that seeks approval for Dr. Simon Green or his associate to participate in the second tranche of the placement. Voting exclusions apply with respect to Resolution 3. Does anyone have any questions with respect to Resolution 3?

David McGarvey

executive
#15

There are no questions.

Kathleen M. Metters

executive
#16

That concludes our discussion on the items of business. I am about to close the voting system. Please ensure that you have cast your vote on all resolutions. So I will pause briefly to allow you time to finalize those votes. Voting is now closed. The results of these votes will be released to the stock exchange later today. As there is no further business, I will declare the meeting closed, and thank you all for attending.

For developers and AI pipelines

Programmatic access to Syntara Limited earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.